i started semaglutide at 52 after struggling One Year on Changed My Life Semaglutide: A Weight Loss Breakthrough

The long-acting GLP-1 agonists segment held the largest market share of 63% in 2025, driven by the offering of once-weekly dosing, which drastically enhances patient adherence over daily therapies

Here are some strategies to consider: Start low, go slow : Starting with a low dose and gradually increasing it allows the body to adjust, potentially reducing nausea and other GI issues

SimE.WaltersK.BoukouvalaS.2008Arylamine N-acetyltransferases: from structure to function.403(2008),479510,0360-2532 101

You can join in-person and virtual workshops that make it easier to stay motivated and connected throughout your journey